UBS Asset Management Americas Inc. lessened its stake in shares of Monsanto (NYSE:MON) by 40.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 1,395,195 shares of the basic materials company’s stock after selling 947,993 shares during the quarter. UBS Asset Management Americas Inc.’s holdings in Monsanto were worth $162,931,000 as of its most recent SEC filing.
Several other institutional investors also recently added to or reduced their stakes in MON. Meyer Handelman Co. raised its holdings in Monsanto by 0.6% during the third quarter. Meyer Handelman Co. now owns 124,552 shares of the basic materials company’s stock worth $14,923,000 after buying an additional 706 shares during the last quarter. Toronto Dominion Bank raised its holdings in Monsanto by 6.3% during the third quarter. Toronto Dominion Bank now owns 1,014,313 shares of the basic materials company’s stock worth $121,519,000 after buying an additional 59,750 shares during the last quarter. Amalgamated Bank raised its holdings in Monsanto by 2.0% during the third quarter. Amalgamated Bank now owns 52,909 shares of the basic materials company’s stock worth $6,340,000 after buying an additional 1,022 shares during the last quarter. Janus Henderson Group PLC raised its holdings in Monsanto by 57.1% during the third quarter. Janus Henderson Group PLC now owns 2,342,693 shares of the basic materials company’s stock worth $280,696,000 after buying an additional 851,369 shares during the last quarter. Finally, Oakbrook Investments LLC raised its holdings in Monsanto by 7.4% during the third quarter. Oakbrook Investments LLC now owns 20,350 shares of the basic materials company’s stock worth $2,438,000 after buying an additional 1,400 shares during the last quarter. Institutional investors own 73.70% of the company’s stock.
Several research firms have weighed in on MON. Wells Fargo & Co restated a “market perform” rating and set a $128.00 price objective (up previously from $118.00) on shares of Monsanto in a report on Wednesday, January 17th. Deutsche Bank restated a “buy” rating on shares of Monsanto in a report on Tuesday, January 16th. Royal Bank of Canada restated a “hold” rating and set a $128.00 price objective on shares of Monsanto in a report on Wednesday, November 15th. Finally, Zacks Investment Research downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a report on Monday, December 11th. Eleven analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $127.30.
Shares of Monsanto (NYSE:MON) opened at $120.79 on Monday. Monsanto has a one year low of $108.51 and a one year high of $123.15. The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 1.05. The stock has a market cap of $53,244.33, a price-to-earnings ratio of 21.08, a PEG ratio of 1.73 and a beta of 1.01.
Monsanto (NYSE:MON) last posted its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.42 by ($0.01). Monsanto had a return on equity of 40.13% and a net margin of 16.38%. The firm had revenue of $2.66 billion during the quarter, compared to the consensus estimate of $2.77 billion. During the same quarter in the previous year, the company earned $0.21 EPS. The business’s revenue was up .3% compared to the same quarter last year. research analysts expect that Monsanto will post 5.76 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, April 6th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Thursday, April 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.79%. Monsanto’s payout ratio is 39.85%.
In other news, EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the sale, the executive vice president now owns 56,743 shares in the company, valued at approximately $6,772,277.05. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.70% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “UBS Asset Management Americas Inc. Reduces Position in Monsanto (MON)” was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/19/ubs-asset-management-americas-inc-reduces-position-in-monsanto-mon.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.